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Trends
LTPs facilitate the essential movement
of lipid across aqueous spaces and are
deﬁned by in vitro experiments.
Recent developments include a novel
concept of countercurrent lipid transfer
and identiﬁcation of additional LTP
families by bioinformatics.
In vivo and in vitro data have yet to
converge to one complete model.
Advances in in vitro characterisation of
LTPs provide an opportunity to unite
biochemical experimentation to cellu-
lar function.
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Transfer of lipid across the cytoplasm is an essential process for intracellular
lipid trafﬁc. Lipid transfer proteins (LTPs) are deﬁned by highly controlled in
vitro experiments. The functional relevance of these is supported by evidence
for the same reactions inside cells. Major advances in the LTP ﬁeld have come
from structural bioinformatics identifying new LTPs, and from the development
of countercurrent models for LTPs. However, the ultimate aim is to unite in vitro
and in vivo data, and this is where much progress remains to be made. Even
where in vitro and in vivo experiments align, rates of transfer tend not to match.
Here we set out some of the advances that might test how LTPs work.
What Are Lipid Transfer Proteins for?
Along with vesicular trafﬁc between organelles, which is a major subject in membrane cell
biology, there are nonvesicular routes for intracellular trafﬁc. Prominent among molecules that
trafﬁc by nonvesicular means are lipids that are interchanged between membrane-bound
organelles. While lipids are transported as constituents of membrane vesicles, organelles such
as mitochondria derive lipids entirely by nonvesicular routes. Pioneering work on nonvesicular
lipid trafﬁc focused on the endoplasmic reticulum (ER)–mitochondria route, which has high
capacity in both directions [1]. Subsequently, other nonvesicular routes were found, even within
the secretory pathway. For instance, lipid trafﬁc between the ER and the plasma membrane is
faster than can be accounted by vesicular trafﬁc (half-life, 1–5 min) [2,3]. To solve the riddle of all
of this nonvesicular trafﬁc, lipid transfer proteins (LTPs) were postulated as activities that
mediate lipid transfer across the cytoplasm. By deﬁnition, LTPs stimulate some or all of the
following steps: extracting lipid from a membrane, mobilising lipid into the aqueous cytoplasm,
and re-inserting lipid into a different membrane.
The ﬁrst LTPs were identiﬁed by their ability to recapitulate lipid transfer in cell-free experiments
that contained radio-labelled donor membranes and cold acceptor liposomes [1,4]. LTPs show
varying degrees of speciﬁcity for the lipids they transfer (Table 1). Structural studies showed that
many LTPs shield the hydrophobic portions of the lipid, typically in internal cavities that enclose
the lipid with a mobile protein segment, similar to a box with a lid (Figure 1). This makes it
energetically possible to carry lipids into the cytoplasm. Underlying any speciﬁcity an LTP may
have for a lipid headgroup is a hydrophilic binding site that may be inside or outside the cavity
(Figure 1). By gene duplication large LTP families have arisen, some with widely divergent lipid
speciﬁcities [5]. Some families have counterparts in prokaryotes (Table 1), which also need
LTPs to shuttle lipids between membranes [6].
The search for accelerators of lipid trafﬁc has led to the identiﬁcation of LTPs that meet the in
vitro deﬁnition of recapitulating the lipid transfer activity. However, by solubilising lipids an LTPtim.levine@ucl.ac.uk (T.P. Levine).
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Table 1. Twenty-Three Protein Families Capable of Trafﬁcking Bilayer Lipids
Superfamilya Family Humanb Yeastb Specc Ligandsd First founde Foldf PDBg Refs
FAD/NAD binding 13 2 3 PE ?Other PL cryst. 2010 a pocket 3k7m [94]
GLTPm 4 0 3 GSLs pur. 1982 a 1sx6 [95,96]
Insect allergen repeat
(nitrile-speciﬁer detox)
[Insect]h 3 PLs cryst. 2013 a 4jrb [97]
nsLTP [Plant] 3 PLs pur. 1981 a 1afh [98,99]
Saposin 5 0 3 GSLs pur. 1976 a 1m12 [50,100]
SCP-2 (also called nsLTP) 5 1 3 Sterols PL pur. 1980 a 1c44 [101,102]
Elicitin/cryptogein [Plant] 3 Sterols cryst. 1996 a⁄b 1beo [103]
LppX lipid transporteri Mycobacteria 1 Phthiocerol
dimycocerosate lipids
cryst. 2006 a⁄b 2byo [104]
NPC1 (amino terminus) 2 1 1 Sterols pur. 2008 a⁄b 3gki [105]
NTF2i,j Prokaryotek 3 PLs cryst. 2009 a⁄b 2qgu [6]
ORP 12 7 2+l PI4P sterol PS pur. 1989 b barrel + a helices 1zhy [106,107]
Sec14 (CRAL/TRIO) 28 9 2+ PI PC sterol non-BL pur. 1976 a⁄b 1aua [108,109]
StARkin StART 15 0 1+ PL sterols non-BL pur. 1994 b-grip + a helices 1em2 [110,111]
PITP 5 0 2+ PI PC PA pur. 1974 1kcm [4,112]
Bet v I [Plant] 1 Q3OS cryst. 2000 1fm4 [113]
PRELITRIAP 4 3 1 PA PS hom. 2012 4xzs [19,20,22]
LAM 3 6 1 sterols hom. 2014 None [23]
TULIP BPI/Takeout [14] 0 1+ sterol esters
PLs TAG non-BL
pur. 1978/1974 elongated b-grip +
a helices
2obd [12,114,115]
SMP 5 7 3 PLs hom. 2010 4p42 [9,13]
Lipocalini,j Prokaryotek 1 PLs non-BL pur. 1968 b barrel 3e3c [116]
LPS transport (LptACD)i Prokaryote 1 LPS gen. 2008 b jellyroll 2r19 [117]
NPC2/GM2AP 4 1 3 Sterols GM2 pur. 1979 b sandwich 1nep/1pub [118–120]
WIF-1 1 0 1+ PC cryst. 2010 b sandwich 2ygn [121]
aSuperfamilies include two families or more that share structure but not sequence as determined by conventional searches [9,51]. Abbreviations are presented in m.
bNumber of genes coding for intracellular lipid transfer proteins in humans and budding yeast (Saccharomyces cerevisiae).
cNumber of lipid species, as identiﬁed by differing headgroups or conjugated groups, bound by a single typical LTP in this family.
dLipid ligands identiﬁed within the entire LTP family.
eHow and when the family was ﬁrst found: puriﬁed (pur.), crystallised (cryst,), predicted by remote homology (hom.), or by genetics (gen.); dates of publication were
between 1968 and 2014.
fLTP families are classiﬁed according to the Structural Classiﬁcation of Proteins system [87].
gAccession code for the earliest solved structure (where available).
hSquare brackets indicate extracellular proteins.
iLTPs in this family are conﬁned to prokaryotes.
jProteins with this fold vary in overall size, and only some are large enough to bind bilayer lipids.
kNone of the many metazoal lipocalin domain containing proteins have cavities large enough for bilayer lipids.
l
‘+’ indicates that detailed studies show that some LTPs in this family bind additional lipids, signiﬁcance as yet unknown. This may turn out to be a general feature of any
LTP studied in detail.
mAbbreviations: CRAL, cellular retinaldehyde binding protein; GLTP, glycolipid transfer protein; GM2AP, ganglioside GM2 activator protein; GSL, glycosphingolipid;
LPS, lipopolysaccharide; non-BL, nonbilayer lipid; NPC, Niemann–Pick type C proteins; nsLTP, nonspeciﬁc LTP (same name applies to a family of plant LTPs and a
wide-spread family that is also called SCP-2 for sterol carrier protein-2); NTF2, nuclear transport factor-2; PL, phospholipid; Q3OS, quercetin-3-O-sophoroside; TAG,
triacylglycerol; TRIO, triple functional domain protein; WIF, Wnt inhibitory factor.can act equally well as a lipid sensing protein or as a lipid presenting protein, which would lead
to signalling or lipid modiﬁcation (Figure 2) [7]. Mechanistic understanding is required to
distinguish between these possibilities, though they may not be mutually exclusive and may
also depend on the physiological state of a cell. This article reviews recent advances and
describes how future progress might be made using in vivo and in vitro experimental
approaches that test the role of LTPs in net lipid transfer.Trends in Biochemical Sciences, July 2017, Vol. 42, No. 7 517
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(B)  CPTP + C1P
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Figure 1. Different Modes by Which Lipid Transfer Proteins Solubilise Membrane Lipids. (A) MlaC (a periplasmic protein)
crystallises with phosphatidylethanolamine (PE) but does not interact with its headgroup [6]. (B) Ceramide 1-phosphate
(C1P) transfer protein (CPTP) binds the lipid with a hydrophilic patch outside the cavity. (C) Osh4p, a yeast relative of
oxysterol binding protein (OSBP), binds phosphatidylinositol-4-phosphate (PI4P) or sterol, with two internal hydrophilic
patches. (D) Sfh1, a close homologue of Sec14 in yeast, binds phosphatidylinositol (PI) or phosphatidylcholine (PC), with
two internal hydrophilic patches. In both (C) and (D), the lipid is almost entirely shielded from solvent access, but these lipid
transfer proteins differ in that for Osh4 (C) there are conformational changes associated with different lipid occupancy,
particularly in the mobile lid. By contrast, for Sec14 and homologues including Sfh1 (D), there is no signiﬁcant external
response to internal occupancy. Left-hand panels: ribbon diagrams with background showing space-ﬁlling proﬁles and
lipid ligands as space-ﬁll format (coloured by atom: C = green, O = red, N = blue, P = magenta). Other panels: cartoons
with lipid binding pockets lined according to key and major ligands: one in (A) and (B); two in (C) and (D) where the ligands
shown in the ribbon diagrams are PI4P and PI, respectively. Ribbon diagrams taken from PDB ﬁles with accession
numbers: 2qgu, 4k8n, 1zhy, 3spw, 3b7n, and 3b7q.Redrawing the Picture of Lipid Trafﬁc
The LTP ﬁeld has been reinvigorated this decade by a few major developments. Here we
describe in detail two recent advances: an increase in the number of known LTPs, particularly at
membrane contact sites; and an unexpected ﬁnding that oxysterol binding protein (OSBP)-
related proteins (ORPs) solubilise phosphatidylinositol (PI) 4-phosphate (PI4P), which provides
a way to generate lipid gradients.
LTP Numbers Have Risen Dramatically since 2010, Especially at Contact Sites
The number of LTPs that are known to exist has increased partly as a result of predictions using
structural bioinformatics tools such as HHsearch, which detects remote homology with great518 Trends in Biochemical Sciences, July 2017, Vol. 42, No. 7
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Figure 2. Schematic Illustrations of the Various Functions of a Lipid Binding Domain. (A) Lipid trafﬁc by lipid transfer
proteins (LTPs). Either transfer or exchange of lipid can take place at one membrane. Here a countercurrent model is
shown, where one LTP (blue) exchanges two lipids (numbered 1 and 2, shown in green and red, respectively) between two
membranes. In this example, a steep gradient of Lipid #2 is maintained by its synthesis from Lipid #3 (orange) on the left
side, and conversion back to Lipid #3 on the right side. Such a gradient can drive the counterexchange of Lipid #1 up a
gradient, albeit this gradient is less steep than that of Lipid #2. This has been shown for oxysterol binding protein (OSBP)
homologues, where Lipid #2 is phosphatidylinositol-4-phosphate, Lipid #3 is phosphatidylinositol, and Lipid #1 can be
either sterol or phosphatidylserine [38]. (B) LTP as a sensor: An LTP directly senses a lipid if it changes conformation upon
binding a lipid and passes that information to a binding partner. Here an interaction is shown between a signalling protein
and lipid-bound LTP, whereas the non-lipid-bound form does not interact. This might lead to lipid-dependent signalling, as
has been shown for OSBP [48]. Lipid-dependent conformations could also be important for lipid transfer reactions, for
example, in membrane targeting (not shown). (C) LTP as a presenter: the LTP–lipid interaction exposes part of the lipid
(typically the headgroup) to other proteins, for example, an enzyme (purple) that modiﬁes the lipid (turns from green to red).
This applies to the presentation of glycosphingolipids to hydrolytic enzymes by GM2 activator protein (GM2AP) [49]. LTPs
that enclose lipid inside a cavity, such as Sec14, may still present lipids as they enter or leave the cavity (not shown) [43]. (D)
LTP with an additional lipid modifying function: a protein that can solubilise a lipid ligand will thereby have properties of an
LTP; the same protein may also act as a lipid modifying enzyme with other substrates, as is the case for GM2AP when it
interacts with phosphatidylcholine and platelet activating factor [52].sensitivity [8]. The ﬁrst example is the discovery that so-called synaptotagmin, mitochondrial
and lipid binding protein (SMP) domains of previously unknown function are intracellular
homologues of extracellular tubular lipid binding proteins (TULIPs) [9]. These are known to
trafﬁc lipids [10], and contain dimeric LTP domains that can form a long hydrophobic tunnel
[11,12]. Bioinformatic approaches predicted SMP domains as intracellular TULIPs, and there-
after crystal structures were obtained for the SMP domains of extended-synaptotagmin-2 (E-
Syt2) [13] and Mdm12 [14]. Like extracellular TULIPs, SMP domains dimerise to form a long
hydrophobic tube that binds up to four lipids (two per monomer). The TULIP domain of E-Syt2
binds glycerolipids preferentially to sterol by a factor of up to 5:1 [13,15]. While E-Syt2 shows
little or no headgroup speciﬁcity, Mdm12 shows considerable speciﬁcity for cationicTrends in Biochemical Sciences, July 2017, Vol. 42, No. 7 519
headgroups [16], possibly because of binding to the acidic side chain D255, found only in
Mdm12 [14].
Remote structural homologies have also added two large LTP families to the StARkin super-
family, which includes proteins related to the steroidogenic acute response protein (StAR) and
homologues of the major allergen from birch Betula verrucosa (Bet v I) (Table 1) [17]. The ﬁrst
new StARkin family contains the PRELI proteins (proteins of relevant evolutionary and lymphoid
interest; in yeast called Ups for ‘unprocessed Mgm1’). Unlike intracellular TULIP proteins,
PRELI/Ups proteins had been previously implicated in lipid metabolism [18]. Their predicted
role as LTPs [19] has since been strengthened by PRELI/Ups crystal structures [20–22]. These
show PRELI/Ups in complex with a small accessory subunit TP53-regulated inhibitor of
apoptosis-1, (TRIAP1; Mdm35 in yeast), which adds extra helices on to the StARkin b-grip
domain, structurally similar to an extra helix found in PI/phosphatidylcholine (PC) transfer
protein (PITP) members of the StARkin superfamily (Table 1). The other new family of StARkin
proteins contains the LTPs anchored at membrane contact sites (LAMs), a group of proteins
with no prior link to lipid metabolism [23]. In this family, the prediction of a StARkin structure is
supported by ﬁndings that they transfer sterol in vitro [24].
Virtually all intracellular TULIPs and LAMs studied so far are found at contact sites [25]. These
are narrow (10–30 nm) gaps between organelles that can be spanned by individual proteins.
Contact sites have been found between an increasingly wide range of organelles [25–27]. They
were already known to contain a range of LTPs, in particular and many OSBP-related proteins
(ORPs, in yeast also called OSBP homologues, Osh), ceramide transfer protein (CERT), PITPs
related to RdgB in ﬂies (Nir in humans) [28], and possibly the glycolipid transfer protein four-
phosphate adaptor protein-2 (also called FAPP2) [29]. These LTPs use similar combinations of
domains to target contacts between the ER and organelles of the exocytic and endocytic
pathways. The intracellular TULIP and LAM families all localise to contact sites in a different way,
as they are irreversibly embedded in the ER through transmembrane domains.
In addition to these predictions from remote homology, during the same period (2010 to
present day) three unexpected LTP families were discovered through structural work that
revealed proteins with cavities containing bilayer lipids (Table 1). Thus, structural approaches
overall have increased LTP numbers considerably (80 ! 106 in humans, 18 ! 37 in yeast).
Two Lipids Drive Faster Than One
New mechanistic understanding of lipid trafﬁc has grown from a detailed analysis of anomalies in
lipid trafﬁc by ORPs: PI4P (and to a lesser extent PI4,5P2) was known to strongly inﬂuence ORP-
mediated lipid transfer, but the mechanism was unclear [30]. Work from the labs of Guillaume Drin
and Bruno Antonny resolved this by showing that Osh4 not only binds the headgroups of PIPs via
basic residues on its surface but can also transfer PI4P [31]. For the transfer activity, PI4P binds
inside the hydrophobic cavity at a site that overlaps the previously characterised internal sterol
binding site (Figure 1C) [31]. The PI4P binding site is the most conserved part of ORPs, thus PI4P is
likely to be the common ligand among them. This ﬁnding and its interpretation have transformed
the ﬁeld because they have led to a model where ORPs at ER contact sites can drive forward the
trafﬁc of one lipid in a countercurrent that is powered by PI4P.
One of the key facts in the countercurrent model is that PI4P is synthesised by PI 4-kinases (3 in
yeast, 4 in humans) in the cytofacial leaﬂet of the late Golgi, plasma membrane, or endosomes,
and that PI4P is destroyed in the ER by Sac1. The implication of the internal binding site for PI4P
is that any ORP can transfer it from a site of synthesis to the ER. Because PI4P is hydrolysed at
this site, the same ORP is unlikely to pick up PI4P for trafﬁc out of the ER. Instead, it will take
another lipid. The second speciﬁcity for ORPs varies: for OSBP and Osh4 it is sterol, for ORP5/8520 Trends in Biochemical Sciences, July 2017, Vol. 42, No. 7
and Osh6/7 it is phosphatidylserine (PS) [32–34], and it is not known in other cases (e.g., Osh3
[35]). Thus, the asymmetric distribution of PI 4-kinase and PI 4-phosphatase can create multiple
lipid gradients (Figure 2A) [36,37]. In this way, ORPs resemble ion antiporters carrying out
secondary active transport of one ion up a gradient by harnessing the energy created by
another ion ﬂowing down a steeper gradient. Among the strongest in vivo evidence that
supports the countercurrent model is the recruitment of PI 4-kinases and ORPs to viral
replication sites that become highly enriched in both PI4P and cholesterol [38]. Lipid counter-
currents are likely to be highly efﬁcient at membrane contact sites, as shown by the rapid
delivery of PS from ER to plasma membrane in yeast [34]. However, contacts are not
mechanistically essential for countercurrent [31,37].
Asymmetries in lipid distribution are seen throughout the cell [39,40]. The countercurrent model
of ORP function is very appealing because it explains how some of the asymmetries in lipid
distribution might be achieved. Nevertheless, more detailed studies are required to determine
whether the production rate of PIPs can match the required lipid transfer rate. The model has
raised the importance of considering second lipids for LTPs other than ORPs [41]. Other LTPs
with second lipids that might engage in countercurrent include alpha-tocopherol transfer
protein among other Sec14 homologues [42,43] and RdgB/Nir [44,45], where PI is likely to
be the lipid under metabolic control.
The focus on countercurrents prompts a greater interest in minor ligands for all other LTPs,
especially if they could engage in a countercurrent. For example, CERT mediates the transfer of
ceramide from the ER to the trans-Golgi network (TGN). After delivery, ceramide is converted to
sphingomyelin with co-production of DAG, which is potentially toxic to the TGN. The minor
ability of CERT to solubilise and transfer DAG [46] may therefore be physiologically relevant, and
ceramide plus DAG may engage in a countercurrent mediated by CERT to extract DAG from
the TGN, and to deliver ceramide.
Nonlipid Transfer Functions for LTPs
In addition to transferring lipids, LTPs can also act as lipid sensors and lipid presenters. For
example, some StARkin domains are found in transcription factors, where their ability to bind
lipid correlates with transcription [47]. For LTPs to act as lipid sensors, LTP–lipid interactions
must produce unique structural conformations (Figure 1A–C) that then cause signalling events
(Figure 2B). To establish a function in lipid sensing, it is important to exclude lipid transfer as the
cause of the LTP-derived signal. The easiest way to separate the two activities might be to
show that the main function of an LTP is (or is not) lipid transfer, for example, by heterologous
replacement (see below).
LTPs may also function as lipid presenting proteins (also called lipid chaperones [5]) when they
present part of a lipid, typically the hydrophilic head group, to another protein (Figure 2C). For
example, GM2 activator protein (GM2AP) presents glycolipids such as GM2 to a hydrolysing
enzyme HexA, acting as an essential enzyme cofactor [48]. Some presenting proteins such as
saposins are LTPs, but they are also called ‘liftases’, because they lift lipids out of the bilayer,
enhancing access to them by enzymes [50]. Presentation of lipids by LTPs such as Sec14 and its
homologues, where bound lipid is located entirely within an internal cavity (Figure 1D), has been
proposed to occur during lipid entry into and exitout of the binding pocket, in whichcase the act of
lipid exchange is key [43]. In addition, lipid presentation may occur between cells, for example, by
the CD1 major histocompatibility complex, which presents lipid headgroups to T-cell receptors
[51].
Finally, LTPs can have lipid-modifying functions (Figure 2D). For example, GM2AP not only
presents the sphingolipid GM2, but also has a hydrolase activity for glycerolipids that haveTrends in Biochemical Sciences, July 2017, Vol. 42, No. 7 521
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Figure 3. The Minimal Number of Steps
in a Lipid Transfer Reaction. The overall
lipid transfer reaction can be dissected
into eight substeps. 1: lipid transfer pro-
tein (LTP) binds to donor membrane. This
step may be regulated by lipid occupancy
and membrane composition to reduce
irrelevant membrane interactions. 2: Lipid
extraction; or, if the LTP works as a lipid
exchanger, swapping of lipids. 3: LTP–
lipid complex dissociates away from the
membrane. The occupancy of the pocket
can also inﬂuence release of the LTP. 4:
Diffusion between membranes, until the
LTP encounters the acceptor membrane.
Steps 5–8 are essentially as 1–4, but at
the acceptor site. Steps 1–3 and 5–7
should involve conformational changes
(e.g., the closing of a lid after membrane
dissociation of an LTP–lipid complex),
which could make reverse reactions unfa-
vourable. Additional intermediates (pro-
tein conformations) are also possible.choline headgroups, including PC and platelet activating factor (PAF) [52], although the
physiological relevance of this activity is not yet clear. There are other examples where
structural and sequence homologues of LTPs are known as lipid-modifying enzymes
[53,54], and it is appealing to speculate that LTPs originated from lipid-modifying enzymes,
as has been observed for other enzyme–non-enzyme pairs [55].
Approaches to Study Lipid Transfer by LTPs
There are many different experimental approaches to understanding LTPs, with an obvious split
being between in vitro and in vivo experiments. Each approach asks a speciﬁc set of questions
about a lipid transport step, which provides useful information that other approaches may not
probe.
Cell-Free Reconstitution of Lipid Trafﬁc
Even the simplest LTP activity will consist of many discrete steps (Figure 3). To reconstitute such a
reaction, we need puriﬁed LTP, knowledge about the membranes between which it operates to
mimic them with liposomes, and various readouts to follow the reaction and possibly the individual
steps in real time. In such a reductionist approach, protein activities and individual parameters can
be tested directly one by one. Furthermore, we can gain information on the duration of reaction
steps, the number of protein conformations, and the energy of the reaction.
An in vitro system must adequately approximate the in vivo reaction, which may require many
components and so seems daunting. However, highly complex reactions such as the initiation
of DNA replication [56] or vesicle fusion [57] can be reconstituted in cell-free systems that are
highly informative (Box 1). In contrast to these processes, lipid transfer reactions can be
observed with single proteins [4,21]. More complex reconstitutions have now been carried
out with contact site bridging by membrane receptors [58], countercurrent generation by PI 4-
phosphatase [37], and Ca2+-induced lipid transport [15,59]. For lipid countercurrents, it is clear
that LTPs such as ORPs preferentially unload their ﬁrst ligand when the second ligand is
available in the acceptor membrane [31].
Replicating the membrane environment is a difﬁcult issue, accounting for many ways in which in
vitro LTP assays might give false-negative or inefﬁcient results. For example, the donor or522 Trends in Biochemical Sciences, July 2017, Vol. 42, No. 7
Box 1. In Vitro Reconstitution Approaches: Lessons from SNARE-Dependent Membrane Fusion
The complexity of a living cell can hardly be matched by an in vitro reconstitution. However, a continuous effort at
improving a biochemical reaction in a membrane environment can yield enormous insights, as can be shown by the
example of soluble NSF attachment protein (SNAP) receptor (SNARE) proteins and membrane fusion. One enduring
argument against the importance of SNAREs in membrane fusion was that the fusion reaction with liposomes and
puriﬁed SNARE proteins was at ﬁrst very slow [57]. It was difﬁcult to imagine how such a reaction could drive the release
of neurotransmitters in the brain (ﬁve orders of magnitude faster!). It was only through the efforts and persistence of
many researchers over many years that the importance of SNAREs in membrane fusion has become widely accepted
[85]. Several lessons from this venture may be informative for studies of LTPs. Crucial advances were made by (i)
identifying core and accessory factors, (ii) deﬁning rate-limiting steps, and (iii) understanding the impact of membrane
composition, in this case, the lipids. When one compares the initial reconstitution experiments with the most recent
ones, the core machinery remains the same: a set of SNARE proteins distributed between donor and acceptor
membranes. However, including additional proteins and lipids to better mimic the composition of authentic organelles
and understanding several ‘off-pathway’ reactions have together combined to tremendously increase efﬁciency, speed,
and ﬁdelity of the reconstituted reaction [86,87].
The recent increase in interest in lipid transport at membrane contact sites has led to the identiﬁcation of many new
players and many new hypotheses, but also, not surprisingly, to controversies and impatience to have ‘the real answer’.
In the case of SNARE-dependent fusion, in vitro reconstitution assays at ﬁrst only qualitatively approached what
happens in vivo. However, this strategy enabled gradual progress to a point where the reaction in the tube accurately
represents the reaction in the cell, along the way clarifying the contributions of individual players.acceptor composition may produce LTP–membrane interactions that are either too weak for
LTP association or too strong for LTP dissociation [19]. Another factor is that net transfer
between liposomes in vitro will alter lateral pressures in the liposomes’ external leaﬂets unless a
component of the liposomes can ﬂip to rebalance leaﬂet contents. Since ﬂipping is slow for
glycerolipids, assays in vitro might under-report LTP activity. However, there are ways around
this problem by designing assays where the LTP returns a lipid from acceptor to donor [21].
Maybe less obviously, an LTP reaction can also give false positives. If the membrane compo-
sition or the curvature leads to an unstable bilayer, natural barriers to lipid extraction might be
overcome. Reconstitutions can mimic the relevant organelles by using representative lip-
osomes in terms of polar headgroups, acyl chains, and membrane curvature to address
topics such as the inﬂuence of bilayer packing defects on lipid transfer [37].
Other properties of cellular membranes are extremely difﬁcult to replicate in a synthetic system.
These include transverse and lateral heterogeneity and the large number of other proteins,
which leads to crowding [60,61]. Among the elementary steps of the LTP cycle reconstituted in
cell-free reactions, those that are more likely to be affected by experimental approximations are
protein diffusion, and every step that corresponds to an ‘on’ reaction, such as collisions of the
protein with the membranes (Figure 3; Steps 1, 4, 5, and 8). By contrast, ‘off’ reactions should
be less affected by the in vitro approximation because they correspond to dissociation between
well-deﬁned components. Fast reactions require stopped-ﬂow kinetic measurements, but
some steps, such as membrane binding and lipid extraction, are difﬁcult to uncouple experi-
mentally. Limited parts of the LTP reaction cycle can be simulated using molecular dynamics
[34,37].
Other important ingredients that might be missing from current assays are cytosolic or
membrane proteins that reduce the energy barrier to lipid extraction, which is the rate-limiting
step [62]. Some accessory domains that accompany LTPs may alter the stability of the bilayer
locally [63,64]. Some interactions might orient LTPs to enhance their productive interactions
with the membrane. In addition, at high local concentrations, which are found at membrane
contact sites, LTPs and associated domains may show co-operativity. Finally, there are
regulatory interactions that might provide energy inputs that accelerate rates of productive
lipid transfer by LTPs. Phosphorylation–dephosphorylation cycles are known to regulate LTPsTrends in Biochemical Sciences, July 2017, Vol. 42, No. 7 523
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T[65]. In addition, some LTPs interact with chaperones; for example, Osh1 with the AAA-ATPase
Afg2p [66]. The roles of any of these factors have not yet been tested in vitro.
Some Lipid Trafﬁc Pathways Are More Amenable to Study Than Others
When it comes to studying lipid trafﬁc in living cells, some pathways are more difﬁcult to work on
than others. The combination of in vitro speciﬁcity and in vivo localisation of an LTP may suggest
its in vivo activity. However, the key evidence is whether measured rates of in vivo lipid trafﬁc are
affected by changes in LTP levels. Such evidence has been obtained in some examples: (i)
trafﬁc by CERT of ceramide from the ER to the TGN for sphingomyelin synthesis; (ii) uptake by
StAR of cholesterol into mitochondria for steroid hormone synthesis; and (iii) delivery by Ups1p/
Mdm35p of phosphatidic acid (PA) from the outer mitochondrial membrane to the inner
mitochondrial membrane for cardiolipin synthesis (see Figure 4 and Box 2). In these cases,
it has been uncontroversial to suggest that these LTPs mediate net lipid trafﬁc [19,46,67]. In
other cases, it has been far harder to determine the in vivo LTP because important features that
allow the crucial in vivo experiments to work are missing. One of these features is linearity of the
transport pathway. For lipid trafﬁc, connectivity of organelles via membrane contact sites is
often circular, compared with the more linear secretory pathway, at least in its early stages.(A)
Rate = 1/s
Start
End
 (B)
Dn
Dn
Ac
Ac
Rate ≥ 12/s
Key:
Ups1/PRELI
Mdm35/
TRIAP1
PA
NBD–PA
Rhodamine–PE
Donor (Dn)
Acceptor (Ac)
PG CL
igure 4. Discrepancies between Rates of Lipid Transfer Protein (LTP) Transfer In Vitro and In Vivo. (A) In vitro rates of
hosphatidic acid (PA) transfer by Ups1/Mdm35. In highly reproducible, well-controlled assays by Watanabe et al. [21], the
alculated rate at which the LTP moves PA from any one liposome to another = 1/s (details in Box 2A). This is the upper limit
r net trafﬁc. At ‘Start’, the measured emission from 7-nitro-2-1,3-benzoxadiazol-4-yl (NBD)–PA is inhibited as it undergoes
örster resonance energy transfer (FRET) with rhodamine–phosphatidylethanolamine (PE), which emits at 585 nm (yellow
ignal). Note that although NBD–PA and rhodamine–PE are diffusing freely in the donor membrane, they are illustrated close
ogether to indicate the proximity for FRET, which is 2 nm. As the reaction progresses to ‘End’, the measured NBD
uorescence increases as NBD–PA is moved to acceptor liposomes lacking rhodamine–PE, where it emits at 535 nm (green
ignal). (B) Estimate of in vivo rate of PA import into mitochondria in budding yeast. Cardiolipin (CL) is made in the
itochondrial matrix from a phosphatidylglycerol (PG) and a cytidine diphosphate diacylglycerol, each of which is made from
ne imported PA molecule. The lower limit of in vivo PA transfer by Ups1 is estimated to be 12/s (details in Box 2B). This is
12-fold faster than the rate measured in (A). See Box 2 for potential sources of error. Abbreviations: Ac, acceptor; Dn,
onor; PRELI, proteins of relevant evolutionary and lymphoid interest (in yeast called Ups for ‘unprocessed Mgm1’); TRIAP1,
P53-regulated inhibitor of apoptosis-1 (Mdm35 in yeast).
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Box 2. Detailed Analysis of PA Import into Mitochondria by Ups1 in Yeast
(A) Evaluation of In Vitro PA Transfer Assays by Ups1/Mdm35 (Yeast Homologs of PRELI/TRIAP1) in
Watanabe et al. [21].
Analysis of three factors yields a rate of 1/s for the in vitro transfer of PA by Ups1/Mdm35 complexesthat is shown in
diagrammatic form in Figure 4A: (i) the proportion of transfers measured by ﬂuorescence of NBD–PA, (ii) the rate of signal
increase, and (iii) the number of NBD–PA transfers at equilibrium.
(i) Donor (Dn) and acceptor (Ac) liposomes (ratio 1:4, both 100 nm diameter) have initial composition differences: Ac
contains unlabelled PA (1250 nM in external leaﬂet). The PA in Dn is replaced by ﬂuorescent NBD–PA (250 nM in
external leaﬂet), which is quenched by rhodamine–PE present only in Dn. When LTP is added to both Dn and Ac, there is
an increase in NBD ﬂuorescence with ﬁrst-order kinetics, indicating net trafﬁc of NBD–PA from Dn to Ac (Figure 5B in
[21]). We assume equivalent net trafﬁc of PA from Ac to Dn, and that the reaction tends to an equilibrium where the total
PA content of each liposome is composed of a 1:5 ratio of NBD–PA and unlabelled PA. Among the distinct movements
of the LTP, transfer from Dn ! Ac is only one; others will be Dn ! Dn, Ac ! Ac, and Ac ! Dn. Assuming that the LTP
interacts equally with Dn and Ac, the net transfers registered by gain of ﬂuorescence (Dn ! Ac) represent approximately
(17%  83%) = 14% of all transfers.
(ii) Initial rate (the signal increase from t = 5  15 s, after subtraction of background without LTP, as proportion of
maximum signal) = (from Figure 5B in Watanabe 1.4%/set al. [21]).
(iii) Since equilibrium requires 20 nM of LTP to transfer 200 nM of NBD–PA from Dn to Ac, equilibrium occurs when
each LTP has undergone 200/20  10 rounds of such transfer. Thus, the in vitro rate of trafﬁc between any two
liposomes is as follows:
 rate½¼ 1:4%  number rounds½¼ 10
fraction ðtransfers reportedÞ ½¼ 14%  1 =s
Additional analysis of transfer assays using radiolabelled PA in the place of NBD–PA from Connerth et al. [19] yields a
similar rate, indicating that the NBD headgroup does not affect transfer. This rate is also comparable to that measured
for other LTPs, for example, ORPs [31].
(B) Estimate of Minimum In Vivo Rate of PA Import across the Mitochondrial Intermembrane Space in
Budding Yeast
This analysis of in vivo transfer, as shown in diagrammatic form in Figure 4B, uses three approximations to estimate the
lower limit of transfer by Ups1 as 12/s: (i) the minimum synthesis rate of cardiolipin (CL) to reproduce its content in a
single-cell cycle, (ii) the copy number of Ups1 per cell, and (iii) the proportion of PA import mediated by Ups1.
(i) The production of one CL requires delivery of two PA molecules to the inner membrane. Mitochondria in yeast have a
similar surface area [88] and similar amount of lipid [89] to the plasma membrane, which has approximately 2  108
phospholipids (PLs) [90]. Therefore, we assume that the number of mitochondrial PLs per cell is 2  108. CL makes up
15% of mitochondrial PLs [91,92], that is, 3  107/cell. By comparison, levels of all precursors to CL are low (<10% of
CL), and are discounted here. To make this amount of CL, the number of imported PA is 6  107.
Mitochondrial CL must be made at least once per cell cycle (5000 s).
Import rate of PA  6  107=5000 ¼ 12000=s
(ii) The estimated copy number of Ups1 is 700 per cell [93]
(iii) Ups1 carries out approximately 70% of CL import (see Connerth et al. [19], Figure 1B).
Transfer by Upsl  0:7  12 000=700
 12=s
That is, 12-fold faster than rate measured in vitro – see the ‘Evaluation of In Vitro PA Transfer Assays by Ups1/Mdm35
(Yeast Homologs of PRELI/TRIAP1) in Watanabe et al. [21]’ section.
Potential Sources of Error
(i) Overestimate of Ups1 role: some experiments in Connerth et al. [19] indicate that Dups1 has 50% CL synthesis of
wild-type, not 30%, error factor  1.4.
(ii) Overestimate of mitochondrial area; this might include an error by a further factor 3.
If both (i) and (ii) apply, in vivo LTPs transfer rate is still 3/s that is, 3 faster than the measured rate.
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Almost any pair of organelles is linked by a contact site, meaning that lipid can trafﬁc from
A,B,C,A. In such a circular arrangement, blocking any one step still allows lipid to access
all compartments. A well-explored example of this is the lipid trafﬁc pathway ER , vacuole
(yeast equivalent of lysosome) , mitochondria , ER. Blocking either of the routes involving
mitochondria leads to hypertrophy of the other route, which is presumed to be a compensatory
change that allows lipids to reach mitochondria [68,69]. Multiple circularities may explain how
genetic screens fail to identify LTPs along key routes where lipid trafﬁc is highly complex [70].
What Is the Limit for Experiments in Living Cells?
A focus for the future will be to build up techniques that overcome the problems of studying
some lipid transport pathways in vivo. Here we look at three techniques by which we might
advance our understanding of the transfer of lipids between cellular compartments by LTPs.
Lipid Probes to Pulse and Chase
A major difﬁculty for in vivo studies of lipid trafﬁc is to ﬁnd a lipid reporter that allows the study of
transport at high temporal and spatial resolution in an intact environment. The value of
ﬂuorescent lipids is often limited by the effects of large groups on the physicochemical
properties of the native lipid. This can be partly overcome by using reporters with only minimal
changes compared to the original lipid, such as additional conjugated double bonds in either
cholesterol or acyl chains, although these molecules are hard to image [71,72]. Radiolabelled
lipids or precursors have long been used to probe trafﬁc pathways, and they continue to be
useful [1,73], although their value is limited for following intracellular location. One way to deliver
a pulse of lipid is to use caged lipids. These are nonpolar precursors that are activated by light,
and they can be highly informative [74]. Another way to pulse lipid into cells is to add a
nonbilayer precursor, such as a lysolipid, that is rapidly converted into a bilayer lipid. For
example, in yeast lyso-PS is acylated to PS in the ER within 1 min, allowing PS trafﬁc out of the
ER to be followed in a time-resolved manner [32,34]. In addition, lipids added externally can be
minimally modiﬁed, creating so-called bifunctional lipids. Most often two small chemical groups
are added, typically to the acyl chain: azide for photo-crosslinking and alkyne for detection (after
ﬁxation) by click chemistry [75]. So far, this pair of groups has been added only to lipid
precursors such as fatty acid or sphingosine, but their use in bilayer lipids could be informative.
Protein Reporters
The localisation of a particular lipid can also be determined with a protein reporter that binds its
headgroup. The reporter should be detectable when present at low stoichiometry, so its
binding does not affect the total lipid pool. The reporter should also be nonbiased toward
any given lipid pool, which has been achieved for PI4P detection using a bacterial reporter [76].
By contrast, detection of cholesterol with perfringolysin (subunit D) is biased for chemically
active sterol not bound to other lipids, so a large proportion of sterol in the plasma membrane is
undetectable [77]. Future advances might include the development of probes speciﬁc for PC,
phosphatidylethanolamine, and PI, or that can identify all sterols.
Heterologous Replacement
In addition to directly studying lipid trafﬁc, a proposed LTP activity can be inferred when its
function is replaceable with an LTP with the same in vitro speciﬁcity but without sequence
homology (hence heterologous). This has been demonstrated for StARD4, overexpression of
which has similar functional consequences on sterol trafﬁc as microinjection of cyclodextrin, a
small sugar polymer that can transfer sterols [78]. Other experiments are less clear. Deletion of
Ysp2p, a putative sterol transfer protein in yeast, is partially rescued by the unrelated sterol
transfer domain from human StARD3 [73]. Similarly, deletion of Sec14, a PI/PC-speciﬁc
member of the cellular retinaldehyde binding protein/triple functional domain protein (CRAL/
TRIO) superfamily, is partially rescued by an unrelated PI/PC transfer protein from the StARkin526 Trends in Biochemical Sciences, July 2017, Vol. 42, No. 7
Outstanding Questions
How many LTPs are there remaining to
be identiﬁed, and what net transfer of
lipids do they mediate? Increasing the
sensitivity of bioinformatics searches
may help.
What are the lipid speciﬁcities for dif-
ferent LTPs? What ligands are we
missing, and which of the known ones
are false? To what extent does in vitro
data on LTP speciﬁcity match up to
transport in cells? Do additional lipid
ligands power countercurrents?
How often do LTPs not mediate net
trafﬁc of lipids? Developing speciﬁc
assays for lipid sensing and lipid pre-
senting roles for LTPs will more pre-
cisely dissect their overall functions.
What determines the donor and
acceptor membrane speciﬁcities of
LTPs with no accessory domains?
How does the occupancy of an LTP by
a particular ligand affect its interaction
with a speciﬁc membrane, and how
often does this promote net trafﬁc in
cells? So far this has been found for
Osh4 only in vitro, which deposits
ergosterol extremely slowly to ER-type
membranes.superfamily [79]. The lack of strong rescue in both these cases may indicate a greater degree of
complexity, for example, in intracellular targeting.
Genetics (Fast versus Slow Approaches)
Genetic manipulation of one or multiple LTPs has yielded many insights, but there are limits
imposed by the ability of cells to adapt, in particular by hypertrophy of parallel pathways, as we
have described. More subtle approaches may be developed to minimise cellular adaptations to
deletion of LTPs. For example, the problems of cellular adaptation to loss of ER , mitochon-
drial LTPs [68,80] can be mitigated by hyperactive Vps13p mutants that bypass that genetic
lesion, hence preventing gross hypertrophy of vacuole , mitochondrial contacts [81,82]. Other
approaches for the future include rapid relocation of LTPs within cells [83] or using small
molecular inhibitors, such as the ORPhilins to inhibit ORPs [38].
Concluding Remarks: The Eventual Goal Is to Align In Vitro and In Vivo
Experiments
The function of some LTPs is still uncertain. Even though many LTPs are thought to mediate the
net transfer of lipids along speciﬁc routes in cells, these routes have yet to be studied in detail. It
would be a big advance if a combination of in vitro and in vivo techniques was applied to
produce a coherent set of results for each route. One way to link in vitro and in vivo experiments,
perhaps revealing the disparities between them, would be to focus (if only brieﬂy) on estimates
of the rate of lipid transfer arising from each approach. The extent to which these match each
other indicates how close we are to a full understanding (see Outstanding Questions).
Taking sterol trafﬁc in yeast as an example, it has been shown in yeast that Osh4 (30 000
copies per cell, the major ORP in numeric terms) can transfer sterol at a rate of up to 0.5/s
[31]. It is therefore possible that it meets the demand for forward sterol trafﬁc out of the ER
to allow cellular replication (replication requires 10 000 sterols/s) [37]. However, this set
of estimates must be reconciled with other studies that estimate the maximal rate of sterol
trafﬁc is tenfold higher [62]. Other LTP-mediated steps show discrepancies between rates
of transfer measured in vitro and in vivo. We have used the literature to consider one
example in detail: import of PA across the mitochondrial intermembrane space for
cardiolipin synthesis by the Ups1/Mdm35 complex in yeast [19]. In vitro, the LTP complex
can transfer PA at 1 lipid/s (Figure 4A and Box 2A) [21]. However, in vivo, we estimate
each LTP complex imports 12 lipids/s (Figure 4B and Box 2B). Such a fast imputed rate
for in vivo trafﬁc is not unique. For example, StAR has been suggested to transfer sterol at
7/s [84]. In addition, fast nonvesicular lipid trafﬁc is not limited to either sterols or import
into mitochondria, as it appears to occur for ER to plasma membrane trafﬁc of PS [34],
though not all phospholipids have been tested. We interpret these ﬁndings not to say that
the studies cited are in any way ﬂawed. Instead, the discrepancies (here 12-fold) might
stimulate further research.
To understand LTPs, lipid trafﬁc in vivo should be measured accurately. Factors that might
affect lipid transfer should be replicated for assays in vitro. Together, these steps may advance
us toward a more united picture.
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